Chinese Journal of Pharmacovigilance ›› 2010, Vol. 7 ›› Issue (5): 298-299.

Previous Articles     Next Articles

The Security Overview of Sulfonylurea in the Treatment of Type 2 Diabetes During

JIN Feng, LI Lei, GUAN Yu, QU Yi   

  1. Jilin Center for Drug Reevaluation, SFDA, Jilin Changchun 130062, China
  • Received:2016-02-19 Revised:2016-02-19 Online:2010-05-08 Published:2016-02-19

Abstract: With the development of medical standards and pharmaceutical industries, the application of hypoglycemic agents has played a significant role in the treatment of diabetes, but at the same time, drug-induced adverse reactions and rational use of drugs during the treatment of diabetes has also become to be the practical problems. In this paper, through a preliminary dissertation on the safety of sulfonylureas hypoglycemic agents, The purpose is to provide a reference of clinical rational use of drugs.

Key words: Sulfonylurea, type 2 diabetes, Security

CLC Number: